Works by Hayashi, Kazumi


Results: 20
    1
    2
    3
    4
    5
    6

    Phase I/II trial of combination of temozolomide chemotherapy and immunotherapy with fusions of dendritic and glioma cells in patients with glioblastoma.

    Published in:
    Cancer Immunology, Immunotherapy, 2016, v. 65, n. 12, p. 1499, doi. 10.1007/s00262-016-1905-7
    By:
    • Akasaki, Yasuharu;
    • Kikuchi, Tetsuro;
    • Homma, Sadamu;
    • Koido, Shigeo;
    • Ohkusa, Toshifumi;
    • Tasaki, Tetsunori;
    • Hayashi, Kazumi;
    • Komita, Hideo;
    • Watanabe, Nobuyuki;
    • Suzuki, Yuta;
    • Yamamoto, Yohei;
    • Mori, Ryosuke;
    • Arai, Takao;
    • Tanaka, Toshihide;
    • Joki, Tatsuhiro;
    • Yanagisawa, Takaaki;
    • Murayama, Yuichi
    Publication type:
    Article
    7
    8

    Clinical benefits of adding olanzapine to 5-HT<sub>3</sub> receptor antagonist, NK<sub>1</sub> receptor antagonist, and dexamethasone for the prevention of nausea and vomiting in highly emetogenic chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023 from the Japan Society of Clinical Oncology

    Published in:
    2025
    By:
    • Murakami, Michiyasu;
    • Miyata, Yoshiharu;
    • Nakashima, Kazuhisa;
    • Abe, Masakazu;
    • Nishimura, Junichi;
    • Wada, Makoto;
    • Iino, Keiko;
    • Akechi, Tatsuo;
    • Iihara, Hirotoshi;
    • Imamura, Chiyo K.;
    • Okuyama, Ayako;
    • Ozawa, Keiko;
    • Kim, Yong-il;
    • Sasaki, Hidenori;
    • Satomi, Eriko;
    • Takeda, Masayuki;
    • Tanaka, Ryuhei;
    • Nakamura, Naoki;
    • Noda, Mayumi;
    • Hayashi, Kazumi
    Publication type:
    Literature Review
    9

    Efficacy and safety of multi-day antiemetic treatment for patients undergoing multi-day chemotherapy: a systematic review of Clinical Practice Guidelines for Antiemesis 2023 from Japan Society of Clinical Oncology.

    Published in:
    2025
    By:
    • Nakashima, Kazuhisa;
    • Harashima, Saki;
    • Kaneko, Rena;
    • Tanaka, Ryuhei;
    • Abe, Masakazu;
    • Wada, Makoto;
    • Iino, Keiko;
    • Akechi, Tatsuo;
    • Iihara, Hirotoshi;
    • Imamura, Chiyo K.;
    • Okuyama, Ayako;
    • Ozawa, Keiko;
    • Kim, Yong-il;
    • Satomi, Eriko;
    • Takeda, Masayuki;
    • Nakajima, Takako Eguchi;
    • Nakamura, Naoki;
    • Nishimura, Junichi;
    • Noda, Mayumi;
    • Hayashi, Kazumi
    Publication type:
    Literature Review
    10

    Defining the clinical benefits of adding a neurokinin-1 receptor antagonist to control chemotherapy-induced nausea and vomiting in moderately emetogenic chemotherapy: a systematic review and meta-analysis of the clinical practice guidelines for antiemesis 2023 from the Japan society of clinical oncology

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 11, p. 1616, doi. 10.1007/s10147-024-02623-y
    By:
    • Hayashi, Toshinobu;
    • Yamamoto, Shun;
    • Miyata, Yoshiharu;
    • Takeda, Masayuki;
    • Abe, Masakazu;
    • Wada, Makoto;
    • Iino, Keiko;
    • Akechi, Tatsuo;
    • Imamura, Chiyo K.;
    • Okuyama, Ayako;
    • Ozawa, Keiko;
    • Kim, Yong-Il;
    • Sasaki, Hidenori;
    • Satomi, Eriko;
    • Tanaka, Ryuhei;
    • Nakajima, Takako Eguchi;
    • Nakamura, Naoki;
    • Nishimura, Junichi;
    • Noda, Mayumi;
    • Hayashi, Kazumi
    Publication type:
    Article
    11

    Non-pharmacological treatments for anticipatory nausea and vomiting during chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 7, p. 889, doi. 10.1007/s10147-024-02536-w
    By:
    • Kobayashi, Masamitsu;
    • Kako, Jun;
    • Iba, Arisa;
    • Okuyama, Ayako;
    • Ozawa, Keiko;
    • Abe, Masakazu;
    • Wada, Makoto;
    • Akechi, Tatsuo;
    • Iihara, Hirotoshi;
    • Imamura, Chiyo K.;
    • Kim, Yong-Il;
    • Sasaki, Hidenori;
    • Satomi, Eriko;
    • Takeda, Masayuki;
    • Tanaka, Ryuhei;
    • Nakajima, Takako Eguchi;
    • Nakamura, Naoki;
    • Nishimura, Junichi;
    • Noda, Mayumi;
    • Hayashi, Kazumi
    Publication type:
    Article
    12

    2023 Japan Society of clinical oncology clinical practice guidelines update for antiemesis.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 7, p. 873, doi. 10.1007/s10147-024-02535-x
    By:
    • Iihara, Hirotoshi;
    • Abe, Masakazu;
    • Wada, Makoto;
    • Iino, Keiko;
    • Akechi, Tatsuo;
    • Imamura, Chiyo K.;
    • Okuyama, Ayako;
    • Ozawa, Keiko;
    • Kim, Yong-Il;
    • Sasaki, Hidenori;
    • Satomi, Eriko;
    • Takeda, Masayuki;
    • Tanaka, Ryuhei;
    • Nakajima, Takako Eguchi;
    • Nakamura, Naoki;
    • Nishimura, Junichi;
    • Noda, Mayumi;
    • Hayashi, Kazumi;
    • Higashi, Takahiro;
    • Boku, Narikazu
    Publication type:
    Article
    13
    14
    15
    16
    17
    18

    Augmentation of Antitumor Immunity by Fusions of Ethanol-Treated Tumor Cells and Dendritic Cells Stimulated via Dual TLRs through TGF-β1 Blockade and IL-12p70 Production

    Published in:
    PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0063498
    By:
    • Koido, Shigeo;
    • Homma, Sadamu;
    • Okamoto, Masato;
    • Namiki, Yoshihisa;
    • Takakura, Kazuki;
    • Takahara, Akitaka;
    • Odahara, Shunichi;
    • Tsukinaga, Shintaro;
    • Yukawa, Toyokazu;
    • Mitobe, Jimi;
    • Matsudaira, Hiroshi;
    • Nagatsuma, Keisuke;
    • Kajihara, Mikio;
    • Uchiyama, Kan;
    • Arihiro, Seiji;
    • Imazu, Hiroo;
    • Arakawa, Hiroshi;
    • Kan, Shin;
    • Hayashi, Kazumi;
    • Komita, Hideo
    Publication type:
    Article
    19
    20